• 2,500,000 officinal sales units in 2010.
• Capacity of production units: 611,600,000.
• Turnover of 44,7 million dinars realized in 2010.
• 81% of the total turnover obtained from SIPHAT generics.
• 14% of the national production.
• Covering 10% of the country’s needs of drugs.
• 583 agents mobilized and committed to your wellbeing.
• 10 foreign partner laboratories.
• Objectives reached: a growth of 27% of the export turnover in 2010.
• 2,709,250 dinars invested in 2010.
• Perspectives 2011-2014: quintuple value exportations.

Key Dates

• first entry into production (as a production unit of the PCT): 1972
• Creation of (Individualizing of SIPHAT): April 1989
• Getting the first AMM: 1989
• Publicly traded: May 2001

Indicators sale

• Officinal Sale 
• Hospital Sale
  
• Export